|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Loss (income) from discontinued operations, net of tax | |||||
| Adjustments to reconcile net income to net cash provided by operating activities attributable to continuing operations: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Restructuring charges | |||||
| Gains on dispositions of property and other assets | |||||
| Gain on sale of ON Services | |||||
| Impairment charges | |||||
| Share-based compensation expense | |||||
| Multi-employer pension plan withdrawal | |||||
| Other non-cash items, net | |||||
| Change in operating assets and liabilities (excluding the impact of acquisitions and disposition): | |||||
| Receivables | |||||
| Inventories | |||||
| Current contract costs | |||||
| Accounts payable | |||||
| Restructuring liabilities | |||||
| Accrued compensation | |||||
| Contract liabilities | |||||
| Income taxes payable | |||||
| Other assets and liabilities, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Net cash provided by operating activities attributable to continuing operations | |||||
| Cash flows from investing activities | |||||
| Cash paid for acquisitions, net | |||||
| Capital expenditures | |||||
| Proceeds from sale of business | |||||
| Net cash used in investing activities | |||||
| Proceeds from insurance | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities attributable to continuing operations | |||||
| Cash flows from financing activities | |||||
| Proceeds from borrowings | |||||
| Payments on debt and finance obligations | |||||
| Purchase of noncontrolling interests | |||||
| Repurchases of common stock | |||||
| Distributions to noncontrolling interest, net of contributions from noncontrolling interest | |||||
| Payments of debt issuance costs | |||||
| Payment of payroll taxes on stock-based compensation through shares withheld or repurchased | |||||
| Proceeds from Stock Options Exercised | |||||
| Net cash (used in) provided by financing activities | |||||
| Dividends paid on preferred stock | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities attributable to continuing operations | |||||
| Total cash (used in) provided by continuing operations | |||||
| Net cash (used in) provided by operating activities attributable to discontinued operations | |||||
| Net cash provided by (used in) investing activities attributable to discontinued operations | |||||
| Net cash used in financing activities attributable to discontinued operations | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash attributable to discontinued operations | |||||
| Total cash (used in) provided by discontinued operations | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash attributable to continuing operations | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of year | |||||
| Cash, cash equivalents, and restricted cash, end of year | |||||
Loading...